DaVita Inc (DVA)
127.81
+1.70
(+1.35%)
USD |
NYSE |
Apr 19, 16:00
127.40
-0.41
(-0.32%)
After-Hours: 18:27
DaVita SG&A Expense (Quarterly): 401.47M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 401.47M |
September 30, 2023 | 376.88M |
June 30, 2023 | 364.02M |
March 31, 2023 | 331.61M |
December 31, 2022 | 379.71M |
September 30, 2022 | 365.45M |
June 30, 2022 | 315.22M |
March 31, 2022 | 294.82M |
December 31, 2021 | 322.72M |
September 30, 2021 | 293.10M |
June 30, 2021 | 298.09M |
March 31, 2021 | 281.43M |
December 31, 2020 | 304.52M |
September 30, 2020 | 363.28M |
June 30, 2020 | 316.21M |
March 31, 2020 | 263.58M |
December 31, 2019 | 278.42M |
September 30, 2019 | 298.74M |
June 30, 2019 | 275.34M |
March 31, 2019 | 250.81M |
December 31, 2018 | 268.53M |
September 30, 2018 | 336.30M |
June 30, 2018 | 264.09M |
March 31, 2018 | 266.53M |
December 31, 2017 | 265.42M |
Date | Value |
---|---|
September 30, 2017 | 272.91M |
June 30, 2017 | 262.80M |
March 31, 2017 | 262.90M |
December 31, 2016 | 285.10M |
September 30, 2016 | 406.89M |
June 30, 2016 | 386.90M |
March 31, 2016 | 386.43M |
December 31, 2015 | -12.13M |
September 30, 2015 | 353.49M |
June 30, 2015 | 347.96M |
March 31, 2015 | 341.80M |
December 31, 2014 | 355.99M |
September 30, 2014 | 322.82M |
June 30, 2014 | 298.64M |
March 31, 2014 | 284.06M |
December 31, 2013 | 318.83M |
September 30, 2013 | 305.14M |
June 30, 2013 | 268.11M |
March 31, 2013 | 284.41M |
December 31, 2012 | 273.77M |
September 30, 2012 | 197.91M |
June 30, 2012 | 212.79M |
March 31, 2012 | 205.40M |
December 31, 2011 | 186.68M |
September 30, 2011 | 182.64M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
263.58M
Minimum
Mar 2020
401.47M
Maximum
Dec 2023
322.35M
Average
315.22M
Median
Jun 2022
SG&A Expense (Quarterly) Benchmarks
Encompass Health Corp | 743.40M |
HCA Healthcare Inc | 7.57B |
Integer Holdings Corp | 45.80M |
Haemonetics Corp | 111.71M |
Stryker Corp | 1.941B |